Solid Biosciences INC Form 4 insider transactions

Perceptive Advisors LLC, along with related entities and individuals, reported the acquisition of stock options in Solid Biosciences Inc. on June 11, 2024.

Gabriel Brooks, Chief Medical Officer of Solid Biosciences, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.

Director Ian F. Smith of Solid Biosciences Inc. reports the vesting of restricted stock units into common stock on October 3, 2024.

Director Ian F. Smith converted 3,255 restricted stock units into common stock of Solid Biosciences Inc. on July 3, 2024.

Georgia Keresty, a director of Solid Biosciences Inc., was granted a stock option to purchase 34,400 shares of common stock on June 11, 2024.

Director Ian F. Smith reports the acquisition of stock options in Solid Biosciences Inc.

Director Lynne Marie Sullivan reports the acquisition of stock options in Solid Biosciences Inc.

Director Martin I Freed acquired stock options in Solid Biosciences Inc. on June 11, 2024.

Director Nagendran Sukumar of Solid Biosciences Inc. was granted stock options on June 11, 2024.

Director Clare Kahn of Solid Biosciences Inc. reports the acquisition of stock options.

Director Ilan Ganot of Solid Biosciences Inc. reports the acquisition of stock options.

Director Clare Kahn of Solid Biosciences Inc. (SLDB) reported acquiring 1,100 shares of common stock at a price of $7.6742 per share on June 7, 2024.

Director Ilan Ganot reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.

Director Ian F. Smith reported the vesting of restricted stock units into common stock of Solid Biosciences Inc.